TeraPore uses Cornell research to address virus filtration challenges
TeraPore Technologies, co-founded by Rachel Dorin, Ph.D. ’13, and its novel nanofiltration products are changing how the pharmaceutical industry is reducing risk of harmful virus contamination in... Read more about TeraPore uses Cornell research to address virus filtration challenges